Real-time enrollment status for this breast cancer clinical trial
Current Status
Active, Not Recruiting
Checked: June 1, 2026 at 7:01 PM UTC
| NCT Number | NCT06760637 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 1,020 participants |
| Active Locations | 172 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | May 19, 2026 (1 week ago) |
As of June 1, 2026: Clinical trial NCT06760637 is currently active_not_recruiting participants. This clinical trial study for breast cancer is not currently accepting new participants at 172 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06760637 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 172 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06760637 was last updated 1 week ago (May 19, 2026). HelloStudys verifies this status automatically.